Discover how Vaishali Bhosekar, Associate Director of Biostatistics at Novotech navigates her team's dynamic and supportive work environment. Hear about her team's rapid growth, the unique challenges they tackle, and why Novotech stands out as an exceptional place to build a career. Follow us to hear more about #lifeatnovotech
關於我們
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006. The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000 professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice. For more information or to speak to an expert team member visit www.Novotech-CRO.com
- 網站
-
http://www.novotech-cro.com
外部Novotech連結
- 產業
- 生物技術研究
- 公司規模
- 1,001-5,000 名員工
- 總部
- SydneyNSW
- 類型
- 私人所有
- 專長
- Leading Asia Pacific Contract Research Organization (CRO)、Clinical Trials (Phase I to IV clinical research)、Biostatistics、Data Management、Regulatory Affairs、Audits、Medical Writing和Commercialization - across all major therapeutic areas
地點
Novotech員工
動態消息
-
At Novotech, we celebrate milestones and forge lasting connections. Whether in South Korea, Singapore, Prague or Brisbane, our team's passion shines through. Ready to be part of something extraordinary? Find your next role: https://lnkd.in/gAMUVB6F #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro
-
-
Novotech is pleased with the success of our participation in the BIO Plus Interphex Korea 2024 in Seoul from July 10 to 12. Our team met with many of our valued clients to discuss how we can accelerate their global clinical development plans. Elzbieta Rutkowska (Associate Director of Regulatory Affairs) had a very successful presentation on “European Clinical Trials in a Changing Landscape, and Dr. Maria Sorrenti (Senior Director Regulatory Start Up Office) led a highly engaging panel discussion. If you missed the opportunity to meet our team, you can connect with us here: https://lnkd.in/dpBX2xyH Lilian K., Jiyoung(Jai) Kim, Do yoon Kim, Junghoon(Gerard) Kim, Eunkyung Heo, Adrian Jeon, Im Jieun, Wooju Kim, Jonathan Kim #BioPlus #ClinicalResearch #DrugDevelopment
-
#DidYouKnow that every year, 490,000 cases of Leukemia are diagnosed worldwide, and that Chronic Lymphocytic Leukemia (CLL) accounts for around 25% of them? Since 2019, over 1,000 Chronic Lymphocytic Leukemia trials have been initiated for treatments that aim to improve patient outcomes. You can discover key insights into the current state and the latest advancements in CLL research through the in-depth disease analysis provided in Novotech’s report, available for free download via this link: https://lnkd.in/dhZ5Rkwp #CLL #ClinicalResearch #Leukemia
-
-
Working at Novotech feels like being part of a movement. We're not just shaping our careers, but also impacting patient lives. Experience true Impact, join us now at: https://lnkd.in/gBX4Mmh2 #CRA #clinicaltrials #clinicalresearch #cro #lifeatnovotech
-
-
Empowering Your Work-Life Balance Temporarily or permanently adjust your work hours. Find the perfect balance that fits your life and commitments. Follow us to learn more about at - Novotech #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro
-
Join Novotech for an informative webinar on the "Current Status and Prospects of Advanced Therapies in China" on July 26, from 2-3 pm CST. Our diverse panel of experts will explore important aspects of: ▪️Gene Therapy. ▪️Radiopharmaceuticals. ▪️Vaccine Trials in Southeast Asia. ▪️Global impact and ethical considerations for China's biotech and pharma advancements. Register now to secure your spot! Can’t attend live? Register and you’ll be notified when the on-demand recording becomes available. https://lnkd.in/dM8HEvN3 Panelists Include: ▫ Dr. Qingxian Kong, CMO, Chengdu New Radiomedicine Technology Co. Ltd. ▫ Dr. Xiaoye He (何晓烨), Head of Medical & PV for China, Novotech ▫ Chris Chong, Senior Director Clinical Services, Novotech #AdvancedTherapies #BiotechInnovation #NovotechWebinar
-
-
Explore Novotech's latest whitepaper, which highlights recent advancements and market insights in radiopharmaceuticals. #DidYouKnow that over the past five years, global clinical trials in the radiopharmaceutical sector have surged by 96%, led by North America at 42%, followed by the Asia-Pacific region at 28% and Europe at 26%? For more information, download our latest whitepaper- https://lnkd.in/d9B7wXuA #Radiopharmaceuticals #ClinicalTrials #Novotech
-
-
From Adelaide to Melbourne, Hong Kong to China - Novotech's global team brings diverse perspectives. Our collaborative spirit fuels innovation across borders. Join us in shaping the future of clinical research at Novotech #lifeatnovotech #cra #clinicaltrials #clinicalresearch #clinicalresearchassociate #cro
-
-
#Novotech and its subsidiary, Novotech Laboratories, participated in the CBA China 2024 Conference in Suzhou, China last week. Dean Tang, Senior Director of Sales Operations & Corporate Strategy for Novotech China, delivered a session titled "Sino-US Early Clinical Strategy and Case Sharing". Our on-site team showcased our clinical trial and laboratory capabilities, engaging attendees with interactive activities. If you missed the opportunity to meet our team, you can connect with us here: https://lnkd.in/drtfdbNZ #CBAChina2024 #ClinicalTrials #Novotech